Filter News
Area of Research
- (-) Advanced Manufacturing (5)
- (-) Nuclear Science and Technology (8)
- Biology and Environment (18)
- Clean Energy (39)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (2)
- Computer Science (6)
- Fusion and Fission (12)
- Fusion Energy (8)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (92)
- Materials Characterization (1)
- Materials for Computing (14)
- Materials Under Extremes (1)
- National Security (13)
- Neutron Science (67)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (37)
- Transportation Systems (1)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (2)
- (-) Fusion (3)
- (-) Materials Science (5)
- (-) Neutron Science (3)
- (-) Physics (1)
- 3-D Printing/Advanced Manufacturing (19)
- Advanced Reactors (7)
- Bioenergy (2)
- Composites (3)
- Computer Science (2)
- Cybersecurity (1)
- Decarbonization (1)
- Isotopes (3)
- Machine Learning (1)
- Materials (4)
- Molten Salt (3)
- Nuclear Energy (18)
- Space Exploration (5)
- Sustainable Energy (6)
- Transformational Challenge Reactor (2)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.